March 15th, 2016, Vivos Inc. announced the formation of a new, wholly-owned subsidiary, IsoPet® Solutions Corporation, to focus on the vibrant and expanding veterinary oncology market. August
2017, the subsidiary was eliminated and changed into a separate operating division inside the Company.
The IsoPet® Solutions division will focus on bringing RadioGel™ yttrium-90 brachytherapy products to veterinary oncologists to treat dogs and cats suffering from tumor
There are over 150 million pet dogs and cats, with over 1/3 of the households in the US owning at least one dog, and just under 1/3 owning at least one cat. IsoPet® Solutions is
establishing the infrastructure necessary to provide product to veterinary clinics including regulatory clearances and compliance. The division will also provide product awareness and education
to veterinary oncologists. Initial treatments are to be coordinated through the Chair of the Company’s Veterinary Medicine Advisory
Board, Dr. Alice Villalobos.